DJIA 15,660.18 -254.56 -1.60%
NASDAQ 4,266.84 -16.76 -0.39%
S&P 500 1,829.08 -22.78 -1.23%
market minute promo

1.68 0.04 (2.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IDRA $1.68 2.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.59
Previous Close $1.64
Daily Range $1.55 - $1.72
52-Week Range $1.50 - $5.24
Market Cap $198.8M
P/E Ratio -3.57
Dividend (Yield) $0.00 (0.0%)
Volume 590,473
Average Daily Volume 1,423,786
Current FY EPS -$0.44




Drug Makers

Idera Pharmaceuticals, Inc. (IDRA) Description

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants. Website:

News & Commentary

Forget Inovio Pharmaceuticals, Inc.: These 2 Stocks Are Better Buys

These small-cap biotechs have what it takes to succeed in 2016.

Trade-Ideas: Idera Pharmaceuticals (IDRA) Is Today's Weak On High Relative Volume Stock

Why Shares in Idera Pharmaceuticals, Inc. Dropped 10% Today

An update on its progress in advancing drugs to market fell short of investor hopes.

Why Idera Pharmaceuticals Inc. Shares Dropped 36% in 2015

Clinical progress doesn't always translate into a higher share price.

3 Biotech Stocks to Buy in January

Are you looking to put money to work in the biotech sector? Here are three stocks our contributors like right now.

Idera Pharmaceuticals (IDRA): Today's Weak On High Volume Stock

Idera Pharmaceuticals (IDRA) Jumps: Stock Rises 13.7%

5 Outperforming Stocks to Watch

Health Care Sector Update for 12/07/2015: IDRA,XBIT,THLD

Why Idera Pharmaceuticals Shares Soared Today

Positive early-stage trial results boost excitement for IMO-8400.

See More IDRA News...

IDRA's Top Competitors

IDRA $1.68 (2.44%)
Current stock: IDRA
AMGN $141.46 (-1.63%)
Current stock: AMGN
GILD $87.36 (-0.50%)
Current stock: GILD
BIIB $245.11 (-2.81%)
Current stock: BIIB